Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Financial Statements

Compare

4 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Financial Overview

Guangzhou Baiyunshan Pharmaceutical Holdings Company's market cap is currently $5.15B. The company's EPS TTM is $-0.028238938; its P/E ratio is 8.90; and it has a dividend yield of 7.89%. Guangzhou Baiyunshan Pharmaceutical Holdings Company is scheduled to report earnings on March 20, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 75.44B	¥ 74.99B	¥ 75.52B	¥ 70.79B	¥ 69.01B
Gross Profit	¥ 11.45B	¥ 12.52B	¥ 14.19B	¥ 13.28B	¥ 13.23B
Operating Income	¥ 3.02B	¥ 3.60B	¥ 5.12B	¥ 5.07B	¥ 4.79B
EBITDA	¥ 3.95B	¥ 4.90B	¥ 6.49B	¥ 6.22B	¥ 5.82B
Net Income	¥ 2.91B	¥ 2.84B	¥ 4.06B	¥ 3.97B	¥ 3.72B
Balance Sheet
Cash & Short-Term Investments	¥ 23.81B	¥ 22.72B	¥ 21.31B	¥ 22.56B	¥ 22.38B
Total Assets	¥ 84.55B	¥ 81.68B	¥ 78.59B	¥ 74.67B	¥ 66.12B
Total Debt	¥ 20.70B	¥ 12.37B	¥ 11.70B	¥ 11.43B	¥ 9.92B
Net Debt	¥ 5.75B	¥ -5.90B	¥ -9.61B	¥ -11.07B	¥ -12.45B
Total Liabilities	¥ 43.40B	¥ 43.91B	¥ 41.91B	¥ 41.03B	¥ 34.79B
Stockholders' Equity	¥ 37.80B	¥ 35.90B	¥ 34.92B	¥ 32.07B	¥ 29.06B
Cash Flow
Free Cash Flow	¥ -954.34M	¥ 2.31B	¥ 2.48B	¥ 5.62B	¥ 4.42B
Operating Cash Flow	¥ 253.50M	¥ 3.44B	¥ 4.10B	¥ 7.00B	¥ 5.67B
Investing Cash Flow	¥ -3.81B	¥ -5.96B	¥ -3.11B	¥ -7.25B	¥ -931.57M
Financing Cash Flow	¥ -98.13M	¥ -1.01B	¥ -1.98B	¥ 45.95M	¥ -1.49B

Currency in CNY

Guangzhou Baiyunshan Pharmaceutical Holdings Company Earnings and Revenue History

Income Statement >

Guangzhou Baiyunshan Pharmaceutical Holdings Company Debt to Assets

Balance Sheet >

Guangzhou Baiyunshan Pharmaceutical Holdings Company Cash Flow

Cash Flow >

Guangzhou Baiyunshan Pharmaceutical Holdings Company Forecast EPS vs Actual EPS

Earnings >